SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:lup.lub.lu.se:c39bfcaa-dc03-43da-b411-12af02946532"
 

Sökning: onr:"swepub:oai:lup.lub.lu.se:c39bfcaa-dc03-43da-b411-12af02946532" > Lipid nanoparticles...

Lipid nanoparticles for local delivery of mRNA to the respiratory tract : Effect of PEG-lipid content and administration route

Ongun, Melike (författare)
University of Copenhagen
Lokras, Abhijeet Girish (författare)
University of Copenhagen
Baghel, Saahil (författare)
University of Copenhagen
visa fler...
Shi, Zhenning (författare)
University of Copenhagen
Schmidt, Signe Tandrup (författare)
Danish Serum Institute, Copenhagen
Franzyk, Henrik (författare)
University of Copenhagen
Rades, Thomas (författare)
University of Copenhagen
Sebastiani, Federica (författare)
Lund University,Lunds universitet,Fysikalisk kemi,Enheten för fysikalisk och teoretisk kemi,Kemiska institutionen,Institutioner vid LTH,Lunds Tekniska Högskola,Physical Chemistry,Physical and theoretical chemistry,Department of Chemistry,Departments at LTH,Faculty of Engineering, LTH,University of Copenhagen
Thakur, Aneesh (författare)
University of Copenhagen
Foged, Camilla (författare)
University of Copenhagen
visa färre...
 (creator_code:org_t)
2024
2024
Engelska.
Ingår i: European Journal of Pharmaceutics and Biopharmaceutics. - 0939-6411. ; 198
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Design of inhalable mRNA therapeutics is promising because local administration in the respiratory tract is minimally invasive and induces a local response. However, several challenges related to administration via inhalation and respiratory tract barriers have so far prevented the progress of inhaled mRNA therapeutics. Here, we investigated factors of importance for lipid nanoparticle (LNP)-mediated delivery of mRNA to the respiratory tract. We hypothesized that: (i) the PEG-lipid content is important for providing colloidal stability during aerosolization and for mucosal delivery, (ii) the PEG-lipid content influences the expression of mRNA-encoded protein in the lungs, and (iii) the route of administration (nasal versus pulmonary) affects mRNA delivery in the lungs. In this study, we aimed to optimize the PEG-lipid content for mucosal delivery and to investigate the effect of administration route on the kinetics of protein expression. Our results show that increasing the PEG-lipid content improves the colloidal stability during the aerosolization process, but has a negative impact on the transfection efficiency in vitro. The kinetics of protein expression in vivo is dependent on the route of administration, and we found that pulmonary administration of mRNA-LNPs to mice results in more durable protein expression than nasal administration. These results demonstrate that the design of the delivery system and the route of administration are important for achieving high mRNA transfection efficiency in the respiratory tract.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)

Nyckelord

Lipid nanoparticle
mRNA therapeutics
Mucosal delivery
Nanomedicine
Pulmonary/nasal administration
Vaccine

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy